Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-6.19 Insider Own1.37% Shs Outstand4.52M Perf Week-5.53%
Market Cap8.50M Forward P/E- EPS next Y-2.49 Insider Trans399.19% Shs Float4.46M Perf Month-12.15%
Income-15.16M PEG- EPS next Q-0.80 Inst Own3.10% Short Float0.97% Perf Quarter2.73%
Sales3.75M P/S2.27 EPS this Y64.76% Inst Trans-6.16% Short Ratio1.10 Perf Half Y-21.01%
Book/sh0.58 P/B3.24 EPS next Y38.82% ROA-83.36% Short Interest0.04M Perf Year-67.70%
Cash/sh2.44 P/C0.77 EPS next 5Y- ROE-216.23% 52W Range0.97 - 6.15 Perf YTD7.42%
Dividend Est.- P/FCF- EPS past 5Y82.03% ROI-553.43% 52W High-69.43% Beta0.59
Dividend TTM- Quick Ratio1.10 Sales past 5Y-15.27% Gross Margin77.34% 52W Low93.93% ATR (14)0.13
Dividend Ex-Date- Current Ratio1.10 EPS Y/Y TTM53.50% Oper. Margin-400.77% RSI (14)44.18 Volatility6.11% 6.29%
Employees17 Debt/Eq1.75 Sales Y/Y TTM5038.36% Profit Margin-404.27% Recom1.00 Target Price20.33
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q65.02% Payout- Rel Volume0.92 Prev Close1.93
Sales Surprise-33.25% EPS Surprise-14.06% Sales Q/Q1598.63% EarningsOct 31 AMC Avg Volume39.55K Price1.88
SMA20-5.29% SMA50-4.84% SMA200-15.53% Trades Volume36,318 Change-2.59%
Date Action Analyst Rating Change Price Target Change
Jan-25-21Initiated Ladenburg Thalmann Buy $8
Oct-16-20Initiated Maxim Group Buy $6
Dec-18-23 07:00AM
Dec-12-23 08:00AM
Nov-29-23 08:00AM
Nov-20-23 07:00AM
Nov-15-23 07:00AM
09:31AM Loading…
Nov-13-23 09:31AM
Nov-03-23 07:00AM
Nov-01-23 09:29AM
Oct-31-23 04:10PM
Oct-25-23 09:21AM
Oct-23-23 04:05PM
Oct-10-23 07:00AM
Oct-09-23 07:00AM
Sep-19-23 01:07PM
11:17AM Loading…
Sep-15-23 11:17AM
Sep-11-23 12:44PM
Sep-08-23 12:49PM
Sep-05-23 01:13PM
Aug-30-23 07:00AM
Aug-18-23 09:55AM
Aug-15-23 10:58AM
Aug-14-23 04:05PM
Aug-11-23 06:28PM
06:30AM Loading…
Aug-08-23 04:05PM
Aug-03-23 07:00AM
Jul-27-23 05:34PM
Jul-13-23 07:00AM
Jun-29-23 07:00AM
Jun-14-23 07:00AM
Jun-08-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-25-23 07:00AM
May-16-23 07:00AM
May-12-23 07:00AM
May-02-23 07:00AM
Apr-28-23 12:55PM
Apr-21-23 09:01AM
Apr-20-23 05:25PM
Apr-19-23 07:00AM
Apr-18-23 04:15PM
Apr-12-23 07:00AM
Mar-28-23 07:00AM
Mar-22-23 07:00AM
Feb-23-23 05:35PM
Feb-14-23 07:00AM
Feb-01-23 07:00AM
Jan-18-23 07:00AM
Jan-05-23 04:15PM
Nov-21-22 06:53AM
Nov-19-22 08:24AM
Nov-02-22 07:00AM
Oct-26-22 07:00AM
Oct-20-22 04:05PM
Oct-19-22 07:00AM
Oct-18-22 07:00AM
Oct-06-22 07:00AM
Oct-05-22 07:00AM
Oct-04-22 07:15AM
Sep-22-22 08:35AM
Sep-12-22 07:00AM
Sep-08-22 07:00AM
Sep-06-22 07:00AM
Aug-29-22 07:00AM
Aug-23-22 07:00AM
Aug-22-22 09:13AM
Aug-17-22 05:46PM
Aug-15-22 08:37AM
Aug-13-22 01:06PM
Jul-28-22 07:00AM
Jul-27-22 07:00AM
Jul-21-22 04:05PM
Jul-13-22 07:00AM
Jul-12-22 07:00AM
Jun-22-22 07:30AM
Jun-16-22 07:30AM
Jun-13-22 07:05AM
May-18-22 07:00AM
Apr-26-22 07:00AM
Apr-21-22 04:05PM
Apr-19-22 07:00AM
Apr-14-22 07:00AM
Apr-08-22 04:05PM
Apr-05-22 07:00AM
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEDRICK MARC HChief Executive OfficerNov 20Sale1.962,0684,053170Dec 15 05:09 PM
Lenk Robert PDirectorNov 16Buy1.951,0001,95025,160Nov 17 07:00 AM
Lenk Robert PDirectorNov 15Buy1.771,0001,77024,160Nov 17 07:00 AM
Lenk Robert PDirectorNov 13Buy1.434,0005,72023,160Nov 15 07:00 AM
Lenk Robert PDirectorNov 10Buy1.452,0002,90019,160Nov 15 07:00 AM
Lenk Robert PDirectorNov 09Buy1.594,1996,67617,160Nov 13 07:00 AM
Lenk Robert PDirectorNov 08Buy1.655,0008,25012,961Nov 13 07:00 AM
Lenk Robert PDirectorNov 07Buy1.646,0009,8407,961Nov 08 07:00 AM
Lenk Robert PDirectorNov 06Buy1.501,3952,0921,961Nov 08 07:00 AM
Clowes HowardDirectorSep 13Buy1.436,99310,02211,693Sep 15 07:00 AM
Petersen GregDirectorSep 11Buy1.7020,00034,06224,166Sep 12 07:00 AM
Clowes HowardDirectorJun 06Buy3.981,0003,9804,700Jun 08 07:00 AM
Clowes HowardDirectorMay 03Buy3.642,5009,1023,700May 04 07:00 AM
Hawkins Richard JDirectorMar 03Buy1.00111Mar 06 07:40 PM